{"id":"https://openalex.org/W4285589154","doi":"https://doi.org/10.1007/s11154-022-09735-8","title":"A new era for oral peptides: SNAC and the development of oral semaglutide for the treatment of type 2 diabetes","display_name":"A new era for oral peptides: SNAC and the development of oral semaglutide for the treatment of type 2 diabetes","publication_year":2022,"publication_date":"2022-07-15","ids":{"openalex":"https://openalex.org/W4285589154","doi":"https://doi.org/10.1007/s11154-022-09735-8","pmid":"https://pubmed.ncbi.nlm.nih.gov/35838946","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9515042"},"language":"en","primary_location":{"id":"doi:10.1007/s11154-022-09735-8","doi":"https://doi.org/10.1007/s11154-022-09735-8","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s11154-022-09735-8","pdf_url":"https://link.springer.com/content/pdf/10.1007/s11154-022-09735-8.pdf","source":{"id":"https://openalex.org/S4210219483","display_name":"Reviews in Endocrine and Metabolic Disorders","issn_l":"1389-9155","issn":["1389-9155","1573-2606"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Reviews in Endocrine and Metabolic Disorders","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s11154-022-09735-8.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005405894","display_name":"Vanita R. Aroda","orcid":"https://orcid.org/0000-0002-7706-4585","observed_orcids":["https://orcid.org/0000-0002-7706-4585"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Vanita R. Aroda","raw_affiliation_strings":["Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. varoda@bwh.harvard.edu","Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA, USA"],"raw_orcid":"https://orcid.org/0000-0002-7706-4585","affiliations":[{"raw_affiliation_string":"Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. varoda@bwh.harvard.edu","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]},{"raw_affiliation_string":"Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070289715","display_name":"Lawrence Blonde","orcid":"https://orcid.org/0000-0003-0492-6698","observed_orcids":["https://orcid.org/0000-0003-0492-6698"]},"institutions":[{"id":"https://openalex.org/I1336053918","display_name":"Ochsner Health System","ror":"https://ror.org/003ngne20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336053918"]},{"id":"https://openalex.org/I2799767083","display_name":"Ochsner Medical Center","ror":"https://ror.org/0290qyp66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336053918","https://openalex.org/I2799767083"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lawrence Blonde","raw_affiliation_strings":["Endocrinology Department, Ochsner Health, New Orleans, LA, USA"],"raw_orcid":"https://orcid.org/0000-0003-0492-6698","affiliations":[{"raw_affiliation_string":"Endocrinology Department, Ochsner Health, New Orleans, LA, USA","institution_ids":["https://openalex.org/I1336053918","https://openalex.org/I2799767083"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059098934","display_name":"Richard E. Pratley","orcid":"https://orcid.org/0000-0002-2912-1389","observed_orcids":["https://orcid.org/0000-0002-2912-1389"]},"institutions":[{"id":"https://openalex.org/I2799648416","display_name":"AdventHealth Orlando","ror":"https://ror.org/02n1cyj49","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799648416"]},{"id":"https://openalex.org/I4405270336","display_name":"AdventHealth","ror":"https://ror.org/00gqase94","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4405270336"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard E. Pratley","raw_affiliation_strings":["AdventHealth Translational Research Institute, Orlando, FL, USA"],"raw_orcid":"https://orcid.org/0000-0002-2912-1389","affiliations":[{"raw_affiliation_string":"AdventHealth Translational Research Institute, Orlando, FL, USA","institution_ids":["https://openalex.org/I2799648416","https://openalex.org/I4405270336"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5005405894"],"corresponding_institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":{"value":4790,"currency":"USD","value_usd":4790},"fwci":2.5911,"has_fulltext":true,"cited_by_count":136,"citation_normalized_percentile":{"value":0.92963823,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"23","issue":"5","first_page":"979","last_page":"994"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oral-semaglutide","display_name":"oral semaglutide","score":0.9789999723434448},{"id":"https://openalex.org/keywords/snac","display_name":"SNAC","score":0.7120000123977661},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.8640000224113464},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.902999997138977},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9670000076293945},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8930000066757202},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.9010000228881836},{"id":"https://openalex.org/keywords/cardiovascular-outcomes","display_name":"cardiovascular outcomes","score":0.7770000100135803},{"id":"https://openalex.org/keywords/pioneer-trial","display_name":"PIONEER trial","score":0.8050000071525574}],"concepts":[{"id":"https://openalex.org/C2909862629","wikidata":"https://www.wikidata.org/wiki/Q27261089","display_name":"Semaglutide","level":5,"score":0.9222729206085205},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6836868524551392},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5951153039932251},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.35915976762771606},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.27420711517333984},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000067757","descriptor_name":"Glucagon-Like Peptide-1 Receptor","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000097789","descriptor_name":"Glucagon-Like Peptide-1 Receptor Agonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000099194","descriptor_name":"Semaglutide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002210","descriptor_name":"Caprylates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004763","descriptor_name":"Glucagon-Like Peptides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012964","descriptor_name":"Sodium","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1007/s11154-022-09735-8","doi":"https://doi.org/10.1007/s11154-022-09735-8","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s11154-022-09735-8","pdf_url":"https://link.springer.com/content/pdf/10.1007/s11154-022-09735-8.pdf","source":{"id":"https://openalex.org/S4210219483","display_name":"Reviews in Endocrine and Metabolic Disorders","issn_l":"1389-9155","issn":["1389-9155","1573-2606"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Reviews in Endocrine and Metabolic Disorders","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9515042","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9515042","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rev Endocr Metab Disord","raw_type":"Text"},{"id":"pmid:35838946","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35838946","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Reviews in endocrine & metabolic disorders","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1007/s11154-022-09735-8","doi":"https://doi.org/10.1007/s11154-022-09735-8","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s11154-022-09735-8","pdf_url":"https://link.springer.com/content/pdf/10.1007/s11154-022-09735-8.pdf","source":{"id":"https://openalex.org/S4210219483","display_name":"Reviews in Endocrine and Metabolic Disorders","issn_l":"1389-9155","issn":["1389-9155","1573-2606"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Reviews in Endocrine and Metabolic Disorders","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.7900000214576721}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4285589154.pdf","grobid_xml":"https://content.openalex.org/works/W4285589154.grobid-xml"},"referenced_works_count":80,"referenced_works":["https://openalex.org/W297042459","https://openalex.org/W1535925955","https://openalex.org/W1964579343","https://openalex.org/W1967079645","https://openalex.org/W1997758050","https://openalex.org/W2008173042","https://openalex.org/W2053009138","https://openalex.org/W2058407858","https://openalex.org/W2098083442","https://openalex.org/W2108116968","https://openalex.org/W2138611695","https://openalex.org/W2147519497","https://openalex.org/W2162140339","https://openalex.org/W2463562243","https://openalex.org/W2472538305","https://openalex.org/W2501592124","https://openalex.org/W2519510391","https://openalex.org/W2563047690","https://openalex.org/W2572398654","https://openalex.org/W2593691145","https://openalex.org/W2602700371","https://openalex.org/W2604469807","https://openalex.org/W2724823461","https://openalex.org/W2766836053","https://openalex.org/W2774157762","https://openalex.org/W2787255324","https://openalex.org/W2790574529","https://openalex.org/W2795981708","https://openalex.org/W2800291410","https://openalex.org/W2801715295","https://openalex.org/W2808238332","https://openalex.org/W2894644761","https://openalex.org/W2901306081","https://openalex.org/W2903220880","https://openalex.org/W2903677519","https://openalex.org/W2908397509","https://openalex.org/W2911680209","https://openalex.org/W2912754726","https://openalex.org/W2917730373","https://openalex.org/W2922550132","https://openalex.org/W2929744948","https://openalex.org/W2948370538","https://openalex.org/W2948380809","https://openalex.org/W2948622224","https://openalex.org/W2949925359","https://openalex.org/W2951522032","https://openalex.org/W2953860251","https://openalex.org/W2974621372","https://openalex.org/W2974714926","https://openalex.org/W2979558564","https://openalex.org/W2996266725","https://openalex.org/W2998275298","https://openalex.org/W3004838676","https://openalex.org/W3014953461","https://openalex.org/W3017978130","https://openalex.org/W3018053472","https://openalex.org/W3024880155","https://openalex.org/W3027914904","https://openalex.org/W3030007836","https://openalex.org/W3041811832","https://openalex.org/W3084893820","https://openalex.org/W3095909321","https://openalex.org/W3106528346","https://openalex.org/W3113844163","https://openalex.org/W3122131477","https://openalex.org/W3137006723","https://openalex.org/W3152050242","https://openalex.org/W3157245446","https://openalex.org/W3161149674","https://openalex.org/W3164680927","https://openalex.org/W3164883407","https://openalex.org/W3174516188","https://openalex.org/W3185651838","https://openalex.org/W3195404919","https://openalex.org/W3195888071","https://openalex.org/W3198399789","https://openalex.org/W3199685641","https://openalex.org/W4200161106","https://openalex.org/W4200347668","https://openalex.org/W4206445899"],"related_works":["https://openalex.org/W4400502657","https://openalex.org/W3201282972","https://openalex.org/W2997605969","https://openalex.org/W3199831757","https://openalex.org/W3159005948","https://openalex.org/W3199150848","https://openalex.org/W2969554423","https://openalex.org/W4408894583","https://openalex.org/W4285270192","https://openalex.org/W4401417954"],"abstract_inverted_index":{"Glucagon-like":[0],"peptide-1":[1],"(GLP-1)":[2],"receptor":[3],"agonists":[4],"(GLP-1RAs)":[5],"were":[6],"first":[7,128],"introduced":[8],"for":[9,87,236],"the":[10,20,34,127,147,164,168,226],"treatment":[11,234],"of":[12,26,96,109,150,217,228],"type":[13],"2":[14],"diabetes":[15],"(T2D)":[16],"in":[17,63,69,192,210,225],"2005.":[18],"Despite":[19],"high":[21,104],"efficacy":[22,203],"and":[23,59,103,156,158,183,189,204],"other":[24],"benefits":[25],"GLP-1RAs,":[27],"their":[28],"uptake":[29],"was":[30,81,111,177],"initially":[31],"limited":[32],"by":[33,42,114],"fact":[35],"that":[36,50,135],"they":[37],"could":[38,139],"only":[39],"be":[40,140],"administered":[41,130],"injection.":[43],"Semaglutide":[44],"is":[45],"a":[46,76,91,120,211,222],"human":[47],"GLP-1":[48],"analog":[49],"has":[51],"been":[52],"shown":[53,178],"to":[54,65,125,146,179],"significantly":[55],"improve":[56],"glycemic":[57],"control":[58],"reduce":[60,180],"body":[61,184],"weight,":[62,100],"addition":[64],"improving":[66],"cardiovascular":[67],"outcomes,":[68],"patients":[70,193],"with":[71,90,117,142,187,194,196],"T2D.":[72],"First":[73],"approved":[74],"as":[75],"once-weekly":[77],"subcutaneous":[78],"injection,":[79],"semaglutide":[80,110,116,176],"considered":[82],"an":[83,218,231],"ideal":[84],"peptide":[85],"candidate":[86],"oral":[88,107,151,175,219],"delivery":[89],"permeation":[92,123],"enhancer":[93],"on":[94],"account":[95],"its":[97],"low":[98],"molecular":[99],"long":[101,148],"half-life,":[102],"potency.":[105],"An":[106],"formulation":[108],"therefore":[112],"developed":[113],"co-formulating":[115],"sodium":[118],"N-(8-[2-hydroxybenzoyl]amino)caprylate,":[119],"well-characterized":[121],"transcellular":[122],"enhancer,":[124],"produce":[126],"orally":[129],"GLP-1RA.":[131],"Pharmacokinetic":[132],"analysis":[133],"showed":[134],"stable":[136],"steady-state":[137],"concentrations":[138],"achieved":[141],"once-daily":[143],"dosing":[144],"owing":[145],"half-life":[149],"semaglutide.":[152],"Upper":[153],"gastrointestinal":[154],"disease":[155],"renal":[157],"hepatic":[159],"impairment":[160],"did":[161],"not":[162],"affect":[163],"pharmacokinetic":[165],"profile.":[166],"In":[167],"phase":[169],"III":[170],"PIONEER":[171],"clinical":[172],"trial":[173],"program,":[174],"glycated":[181],"hemoglobin":[182],"weight":[185],"compared":[186],"placebo":[188],"active":[190],"comparators":[191],"T2D,":[195,229],"no":[197],"new":[198],"safety":[199,205],"signals":[200],"reported.":[201],"Cardiovascular":[202],"are":[206],"currently":[207],"being":[208],"assessed":[209],"dedicated":[212],"outcomes":[213],"trial.":[214],"The":[215],"development":[216],"GLP-1RA":[220],"represents":[221],"significant":[223],"milestone":[224],"management":[227],"providing":[230],"additional":[232],"efficacious":[233],"option":[235],"patients.":[237]},"counts_by_year":[{"year":2026,"cited_by_count":64},{"year":2025,"cited_by_count":35},{"year":2024,"cited_by_count":23},{"year":2023,"cited_by_count":12},{"year":2022,"cited_by_count":2}],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2022-07-16T00:00:00"}